DIRECTOR DEALINGS: Melrose non-exec buys shares; TBC director sells
DIRECTOR DEALINGS: Melrose non-exec buys shares; TBC director sells
Read moreDIRECTOR DEALINGS: Melrose non-exec buys shares; TBC director sells
Read moreTRADING UPDATES: Marlowe turns to loss; AFC Energy sees maiden revenue
Read moreIN BRIEF: PureTech buys remaining 22% stake in Alivio Therapeutics
Read moreIN BRIEF: PureTech Health's Akili secures USD160 million in financing
Read moreEXECUTIVE CHANGES: Ebiquity appoints ITV executive Izlan to board
Read moreTRADING UPDATES: Serica production slips; Epwin confident for future
Read more(Sharecast News) - Biotechnology company Puretech Health said on Thursday that it had narrowed operating losses in 2020 on the back of a reduction in general and administrative expenses and a modest increase in full-year revenues.
Read moreUK earnings, trading statements calendar - next 7 days
Read moreIN BRIEF: PureTech Health's Akili to study AKL-T01 in Covid survivors
Read moreTRADING UPDATES: Contango in offtake talks for coking coal in Zimbabwe
Read moreEXECUTIVE CHANGES: Sureserve executive chair departs after turnaround
Read moreTRADING UPDATES: Angus in Balcombe blow; YouGov buys Canada asset
Read moreTRADING UPDATES: Yellow Cake And Asiamet Resources Plan Fundraises
Read moreIN BRIEF: PureTech Sells 1 Million Karuna Shares; Closes Vor IPO
Read more(Sharecast News) - Clinical-stage biotherapeutics commercialisation company PureTech Health announced on Wednesday that its founded entity Vor Biopharma has closed its initial public offering at a price of $18 per share.
Read more